AAOpt 2023: Understanding nystagmus and providing better patient care
Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.
AAOpt 2023: Preventing dropout in glaucoma due to dry eye
At AAOpt, Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss the intersection of dry eye and glaucoma.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.